These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5764887)

  • 21. The timing of tuberculin tests in relation to immunization with live viral vaccines.
    Brickman HF; Beaudry PH; Marks MI
    Pediatrics; 1975 Mar; 55(3):392-6. PubMed ID: 1143978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunization against measles (rubeola).
    Riley HD
    J Okla State Med Assoc; 1969 Mar; 62(3):107-10. PubMed ID: 5813179
    [No Abstract]   [Full Text] [Related]  

  • 23. Vaccination against measles. Clinical trial of live measles vaccine given alone and live vaccine preceded by killed vaccine. Third report to the Medical Research Council by the Measles Vaccines Committee.
    Practitioner; 1971 Apr; 206(234):458-66. PubMed ID: 4930718
    [No Abstract]   [Full Text] [Related]  

  • 24. Studies on further attenuated live measles vaccine. 3. Selection of less reactive variants of CAM measles vaccine virus.
    Takaku K; Sasada T; Konobe T; Onishi K; Ueda S
    Biken J; 1970 Sep; 13(3):163-8. PubMed ID: 5530510
    [No Abstract]   [Full Text] [Related]  

  • 25. Protection of mumps in children with various underlying diseases: application of a live attenuated mumps and trivalent measles-rubella-mumps (MRM) vaccines in these children.
    Kanesaki T; Baba K; Tsuda N; Yabuuchi H; Yamanishi K; Takahashi M
    Biken J; 1986 Dec; 29(3-4):63-71. PubMed ID: 3304276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atypical measles in children previously immunized with attenuated measles virus vaccines.
    Cherry JD; Feigin RD; Lobes LA; Shackelford PG
    Pediatrics; 1972 Nov; 50(5):712-7. PubMed ID: 5084185
    [No Abstract]   [Full Text] [Related]  

  • 27. [Increase of immunoglobulins G, A, M, D and specific antibodies in a group of children vaccinated against measles by Czechoslovak live vaccine Movivac Sevac].
    Wiedermannová D; Wiedermann D; Bozdĕchová M; Hatiarová Z
    Cas Lek Cesk; 1973 Mar; 112(10):297-301. PubMed ID: 4691543
    [No Abstract]   [Full Text] [Related]  

  • 28. Seroconversion after measles vaccination at nine and fifteen months of age.
    Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
    Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A long-term follow-up study on the efficacy of further attenuated live measles vaccine, Biken CAM vaccine.
    Isomura S; Morishima T; Nishikawa K; Hanada N; Rahman M; Terashima M; Kido S; Ueda S; Takahashi M
    Biken J; 1986 Mar; 29(1):19-26. PubMed ID: 3778422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Certain problems with limits of immunity against measles, mumps and rubella].
    Magdzik W
    Przegl Epidemiol; 1993; 47(1-2):47-53. PubMed ID: 8351387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measles vaccination.
    Norrby EC
    Bull Pan Am Health Organ; 1976; 10(3):196-7. PubMed ID: 1000095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measles immunization status in 1972 among first- and second-grade school children in Danbury, Connecticut.
    Lepow ML; Steele FM; Ross MR; Randolph MF
    Pediatrics; 1975 Mar; 55(3):348-53. PubMed ID: 806881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunologic response and post-vaccination reactions in children vaccinated against measles. I. Assessment of post-vaccination reactions].
    Naruszewicz-Lesiuk D; Kańtoch M; Polna I
    Przegl Epidemiol; 1974; 28(3):315-24. PubMed ID: 4471837
    [No Abstract]   [Full Text] [Related]  

  • 34. Guidelines for measles control in Canada.
    CMAJ; 1988 Mar; 138(6):527-9. PubMed ID: 3345478
    [No Abstract]   [Full Text] [Related]  

  • 35. Age of measles immunization in tropics.
    Mirchamsy H; Shafyi A; Mahinpour M; Nazari P
    Dev Biol Stand; 1978; 41():191-4. PubMed ID: 572788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Fever reaction and the effect on antibody formation of vaccination with commercially available KL measles vaccine, with special reference take-rate of live vaccine and need for additional immunization].
    Santo K; Tatsumi H; Kato K; Hanaya T; Abe S
    Nihon Shonika Gakkai Zasshi; 1969 Apr; 73(4):594-9. PubMed ID: 5817479
    [No Abstract]   [Full Text] [Related]  

  • 37. Influence of moderate malnutrition on morbidity and antibody response following vaccination with live, attenuated measles virus vaccine.
    McMurray DN; Loomis SA; Casazza LJ; Rey H
    Bull Pan Am Health Organ; 1979; 13(1):52-7. PubMed ID: 427297
    [No Abstract]   [Full Text] [Related]  

  • 38. Measles vaccine efficacy: influence of age at vaccination vs. duration of time since vaccination.
    Shelton JD; Jacobson JE; Orenstein WA; Schulz KF; Donnell HD
    Pediatrics; 1978 Dec; 62(6):961-4. PubMed ID: 733424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on further attenuated liver measles vaccine. VII. Development and evaluation of CAM-70 measles virus vaccine.
    Okuno Y; Ueda S; Kurimura T; Suzuki N; Yamanishi K
    Biken J; 1971 Sep; 14(3):253-8. PubMed ID: 5167868
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical experience with mass immunization against measles].
    Budai J; Melis L; Szabó A
    Orv Hetil; 1971 Jul; 112(27):1563-9. PubMed ID: 5165348
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.